Halozyme Therapeutics (HALO) Other Non-Current Assets (2012 - 2026)
Halozyme Therapeutics (HALO) posted Other Non-Current Assets of $55.09 million for Q2 2026, up 8.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Other Non-Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Other Non-Current Assets came in at $53.55 million, down 33.6% from FY2024.
- Annual Other Non-Current Assets shows a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Other Non-Current Assets was $80.6 million in FY2024, $26.3 million in FY2022 (+96.1%) and $13.41 million in FY2021 (-4.6%).
- Quarterly Other Non-Current Assets has run from a low of $13.41 million in Q4 2021 to a high of $80.6 million in Q4 2024 over five years.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2024, with growth of 342.5%; the weakest was Q4 2025, with a decline of 33.6%.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $50.92 million (Q1 2026), $53.55 million (Q4 2025) and $55.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 55.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.09 Mn |
| Mar 31, 2026 | 50.92 Mn |
| Dec 31, 2025 | 53.55 Mn |
| Sep 30, 2025 | 55.70 Mn |
| Dec 31, 2024 | 80.60 Mn |
| Sep 30, 2024 | 80.15 Mn |
| Jun 30, 2024 | 52.48 Mn |
| Mar 31, 2024 | 17.32 Mn |
| Sep 30, 2023 | 18.12 Mn |
| Jun 30, 2023 | 18.41 Mn |
| Mar 31, 2023 | 25.24 Mn |
| Dec 31, 2022 | 26.30 Mn |
| Sep 30, 2022 | 25.78 Mn |
| Jun 30, 2022 | 26.28 Mn |
| Mar 31, 2022 | 22.04 Mn |
| Dec 31, 2021 | 13.41 Mn |
| Sep 30, 2021 | 15.55 Mn |
| Jun 30, 2021 | 15.48 Mn |
| Mar 31, 2021 | 14.00 Mn |
| Dec 31, 2020 | 14.07 Mn |
API Access
Halozyme Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();